Identification, structural modification, and dichotomous effects on human immunodeficiency virus type 1 (HIV-1) replication of ingenane esters from Euphorbia kansui

被引:39
作者
Liu, Qingbo [1 ,2 ]
Li, Wei [1 ]
Huang, Li [3 ]
Asada, Yoshihisa [1 ]
Morris-Natschke, Susan L. [4 ]
Chen, Chin-Ho [3 ]
Lee, Kuo-Hsiung [4 ,5 ]
Koike, Kazuo [1 ]
机构
[1] Toho Univ, Fac Pharmaceut Sci, Miyama 2-2-1, Funabashi, Chiba 2748510, Japan
[2] Shenyang Pharmaceut Univ, Minist Educ, Key Lab Struct Based Drug Design & Discovery, Shenyang 110016, Liaoning, Peoples R China
[3] Duke Univ, Med Ctr, Dept Surg, Surg Sci, Durham, NC 27710 USA
[4] Univ N Carolina, Eshelman Sch Pharm, Nat Prod Res Labs, Chapel Hill, NC 27599 USA
[5] China Med Univ & Hosp, Chinese Med Res & Dev Ctr, Taichung 40402, Taiwan
关键词
Euphorbia kansui; Anti-HIV; Latency-reversing agent; Ingenane; 3-(2-Naphthoyl)ingenol; ANTIRETROVIRAL THERAPY; DITERPENES; ACTIVATION; EXPRESSION; LATENCY; ROOTS;
D O I
10.1016/j.ejmech.2018.07.020
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Euphorbia kansui showed potent anti-HIV-1 activity during screening of a library composed of plant extracts from Euphorbiaceae and Thymelaeaceae families. Bioassay-guided isolation led to identification of ingenane esters as the active compounds. Further chemical modification resulted in 3-(2-naphthoyl) ingenol (23), which exhibited the most potent anti-HIV-1 activity. Compound 23 also acted as an HIV-1-latency-reversing agent on activation of HIV-1 replication in a latently infected U1 cell model and a T cell latent HIV-1 model JLat-A2. (C) 2018 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:618 / 627
页数:10
相关论文
共 21 条
  • [1] Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
    Archin, N. M.
    Liberty, A. L.
    Kashuba, A. D.
    Choudhary, S. K.
    Kuruc, J. D.
    Crooks, A. M.
    Parker, D. C.
    Anderson, E. M.
    Kearney, M. F.
    Strain, M. C.
    Richman, D. D.
    Hudgens, M. G.
    Bosch, R. J.
    Coffin, J. M.
    Eron, J. J.
    Hazuda, D. J.
    Margolis, D. M.
    [J]. NATURE, 2012, 487 (7408) : 482 - U1650
  • [2] In vitro effects of the small-molecule protein kinase C agonists on HIV latency reactivation
    Brogdon, Jessica
    Ziani, Widade
    Wang, Xiaolei
    Veazey, Ronald S.
    Xu, Huanbin
    [J]. SCIENTIFIC REPORTS, 2016, 6
  • [3] Novel Targets for Antiretroviral Therapy Clinical Progress to Date
    Dau, Birgitt
    Holodniy, Mark
    [J]. DRUGS, 2009, 69 (01) : 31 - 50
  • [4] Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
    Finzi, D
    Hermankova, M
    Pierson, T
    Carruth, LM
    Buck, C
    Chaisson, RE
    Quinn, TC
    Chadwick, K
    Margolick, J
    Brookmeyer, R
    Gallant, J
    Markowitz, M
    Ho, DD
    Richman, DD
    Siliciano, RF
    [J]. SCIENCE, 1997, 278 (5341) : 1295 - 1300
  • [5] Picomolar Dichotomous Activity of Gnidimacrin Against HIV-1
    Huang, Li
    Ho, Phong
    Yu, Jie
    Zhu, Lei
    Lee, Kuo-Hsiung
    Chen, Chin-Ho
    [J]. PLOS ONE, 2011, 6 (10):
  • [6] Diterpenes from Euphorbia segetalis
    Jakupovic, J
    Jeske, F
    Morgenstern, T
    Tsichritzis, F
    Marco, JA
    Berendsohn, W
    [J]. PHYTOCHEMISTRY, 1998, 47 (08) : 1583 - 1600
  • [7] Synergistic Reactivation of Latent HIV Expression by Ingenol-3-Angelate, PEP005, Targeted NF-kB Signaling in Combination with JQ1 Induced p-TEFb Activation
    Jiang, Guochun
    Mendes, Erica A.
    Kaiser, Philipp
    Wong, Daniel P.
    Tang, Yuyang
    Cai, Ivy
    Fenton, Anne
    Melcher, Gregory P.
    Hildreth, James E. K.
    Thompson, George R.
    Wong, Joseph K.
    Dandekar, Satya
    [J]. PLOS PATHOGENS, 2015, 11 (07)
  • [8] The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation
    Jordan, A
    Defechereux, P
    Verdin, E
    [J]. EMBO JOURNAL, 2001, 20 (07) : 1726 - 1738
  • [9] Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART
    Kulkosky, J
    Culnan, DM
    Roman, J
    Dornadula, G
    Schnell, M
    Boyd, MR
    Pomerantz, RJ
    [J]. BLOOD, 2001, 98 (10) : 3006 - 3015
  • [10] Gnidimacrin, a Potent Anti-HIV Diterpene, Can Eliminate Latent HIV-1 Ex Vivo by Activation of Protein Kinase C β
    Lai, Weihong
    Huang, Li
    Zhu, Lei
    Ferrari, Guido
    Chan, Cliburn
    Li, Wei
    Lee, Kuo-Hsiung
    Chen, Chin-Ho
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (21) : 8638 - 8646